Diagnosis, evaluation, and treatment of hyponatremia: Expert panel recommendations

American Journal of Medicine

Volumn 126, Issue 10 SUPPL.1, 2013, Pages

  Verbalis, Joseph G ^a   Goldsmith, Steven R ^b   Greenberg, Arthur ^c   Korzelius, Cynthia ^d   Schrier, Robert W ^e   Sterns, Richard H ^f   Thompson, Christopher J ^g  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF COLORADO   (United States)

^f UNIVERSITY OF ROCHESTER   (United States)

^g ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

Author keywords

Antidiuretic hormone; Aquaretics; Hypo osmolality; Natriuresis; Syndrome of inappropriate antidiuretic hormone secretion; Vasopressin; Volume regulation

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CONIVAPTAN; CYTOCHROME P450 3A4; DEMECLOCYCLINE; FUROSEMIDE; HYDROCORTISONE; PLACEBO; THIAZIDE DIURETIC AGENT; TOLVAPTAN; UREA;

ACUTE KIDNEY FAILURE; ARTICLE; BRAIN EDEMA; CEREBRAL SALT WASTING; CONTINUOUS INFUSION; DEMYELINATION; DIURESIS; DIURETIC THERAPY; DIZZINESS; ELECTROLYTE DISTURBANCE; ENDURANCE TRAINING; ENZYME BLOOD LEVEL; EUVOLEMIC HYPONATREMIA; EVALUATION; EXTRACELLULAR FLUID; GASTROINTESTINAL DISEASE; HEADACHE; HUMAN; HYPERGLYCEMIA; HYPERVOLEMIC HYPONATREMIA; HYPOALDOSTERONISM; HYPOKALEMIA; HYPONATREMIA; HYPOPITUITARISM; HYPOTHYROIDISM; HYPOVOLEMIC HYPONATREMIA; INAPPROPRIATE VASOPRESSIN SECRETION; INTRACELLULAR FLUID; LIVER CIRRHOSIS; LIVER FUNCTION TEST; NAUSEA; ORTHOSTATIC HYPOTENSION; OSMORECEPTOR; PLASMA OSMOLALITY; PRIORITY JOURNAL; SIDE EFFECT; SODIUM BLOOD LEVEL; THIRST; TOTAL BODY WATER; TREATMENT DURATION; TREATMENT OUTCOME; UREA NITROGEN BLOOD LEVEL; URIC ACID BLOOD LEVEL; URINARY FREQUENCY; WATER RETENTION; XEROSTOMIA;

EID: 84884874250     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2013.07.006     Document Type: Review

References (217)

1. A. Upadhyay, B.L. Jaber, and N.E. Madias Incidence and prevalence of hyponatremia Am J Med 119 2006 S30 S35
2. J.G. Verbalis The syndrome of inappropriate antidiuretic hormone secretion and other hypoosmolar disorders R.W. Schrier, Diseases of the Kidney and Urinary Tract 7th ed 2001 Lippincott Williams & Wilkins Philadelphia 2511 2548
3. J.G. Verbalis, S.R. Goldsmith, and A. Greenberg Hyponatremia treatment guidelines 2007: expert panel recommendations Am J Med 120 2007 S1 S21
4. R.W. Schrier, P. Gross, and M. Gheorghiade Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia N Engl J Med 355 2006 2099 2112 (Pubitemid 44749318)
5. M.V. DeVita, M.H. Gardenswartz, and A. Konecky Incidence and etiology of hyponatremia in an intensive care unit Clin Nephrol 34 1990 163 166 (Pubitemid 20342876)
6. R.C. Hawkins Age and gender as risk factors for hyponatremia and hypernatremia Clin Chim Acta 337 2003 169 172 (Pubitemid 37329815)
7. L. Bettari, M. Fiuzat, and L.K. Shaw Hyponatremia and long-term outcomes in chronic heart failure - an observational study from the Duke Databank for Cardiovascular Diseases J Card Fail 18 2012 74 81
8. L. Balling, M. Schou, and L. Videbaek Prevalence and prognostic significance of hyponatraemia in outpatients with chronic heart failure Eur J Heart Fail 13 2011 968 973
9. M. Gheorghiade, J.S. Rossi, and W. Cotts Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE Trial Arch Intern Med 167 2007 1998 2005 (Pubitemid 47606641)
10. M. Gheorghiade, W.T. Abraham, and N.M. Albert Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry Eur Heart J 28 2007 980 988 (Pubitemid 47343897)
11. P. Angeli, F. Wong, and H. Watson Hyponatremia in cirrhosis: results of a patient population survey Hepatology 44 2006 1535 1542 (Pubitemid 44953659)
12. R. Wald, B.L. Jaber, and L.L. Price Impact of hospital-associated hyponatremia on selected outcomes Arch Intern Med 170 2010 294 302
13. R.J. Anderson, H.M. Chung, and R. Kluge Hyponatremia: a prospective analysis of its epidemiology and the pathogenetic role of vasopressin Ann Intern Med 102 1985 164 168 (Pubitemid 15157162)
14. M. Miller, J.E. Morley, and L.Z. Rubenstein Hyponatremia in a nursing home population J Am Geriatr Soc 43 1995 1410 1413
15. L. Bettari, M. Fiuzat, and G.M. Felker Significance of hyponatremia in heart failure Heart Fail Rev 17 2012 17 26
16. S. Baldasseroni, R. Urso, and F. Orso Relation between serum sodium levels and prognosis in outpatients with chronic heart failure: neutral effect of treatment with beta-blockers and angiotensin-converting enzyme inhibitors: data from the Italian Network on Congestive Heart Failure (IN-CHF database) J Cardiovasc Med (Hagerstown) 12 2011 723 731
17. A. Gines, A. Escorsell, and P. Gines Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites Gastroenterology 105 1993 229 236 (Pubitemid 23234041)
18. M. Guevara, M.E. Baccaro, and J. Rios Risk factors for hepatic encephalopathy in patients with cirrhosis and refractory ascites: relevance of serum sodium concentration Liver Int 30 2010 1137 1142
19. P. Gines, and R.W. Schrier Renal failure in cirrhosis N Engl J Med 361 2009 1279 1290
20. E. Sola, H. Watson, and I. Graupera Factors related to quality of life in patients with cirrhosis and ascites: relevance of serum sodium concentration and leg edema J Hepatol 57 2012 1199 1206
21. A.E. Ruf, W.K. Kremers, and L.L. Chavez Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone Liver Transpl 11 2005 336 343 (Pubitemid 40458408)
22. W.A. Hackworth, D.M. Heuman, and A.J. Sanyal Effect of hyponatraemia on outcomes following orthotopic liver transplantation Liver Int 29 2009 1071 1077
23. W.R. Kim, S.W. Biggins, and W.K. Kremers Hyponatremia and mortality among patients on the liver-transplant waiting list N Engl J Med 359 2008 1018 1026
24. C. Terzian, E.B. Frye, and Z.H. Piotrowski Admission hyponatremia in the elderly: factors influencing prognosis J Gen Intern Med 9 1994 89 91 (Pubitemid 24059127)
25. S.L. Bennani, R. Abouqal, and A.A. Zeggwagh Incidence, causes and prognostic factors of hyponatremia in intensive care [French] Rev Med Interne 24 2003 224 229 (Pubitemid 36542165)
26. A. Chawla, R.H. Sterns, and S.U. Nigwekar Mortality and serum sodium: do patients die from or with hyponatremia? Clin J Am Soc Nephrol 6 2011 960 965
27. A.A. Leung, F.A. McAlister, and S.O. Rogers Jr. Preoperative hyponatremia and perioperative complications Arch Intern Med 172 2012 1474 1481
28. B. Renneboog, W. Musch, and X. Vandemergel Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits Am J Med 119 2006 71
29. K.F. Gankam, C. Andres, and L. Sattar Mild hyponatremia and risk of fracture in the ambulatory elderly QJM 101 2008 583 588 (Pubitemid 351912001)
30. H.S. Sandhu, E. Gilles, and M.V. DeVita Hyponatremia associated with large-bone fracture in elderly patients Int Urol Nephrol 41 2009 733 737
31. S. Kinsella, S. Moran, and M.O. Sullivan Hyponatremia independent of osteoporosis is associated with fracture occurrence Clin J Am Soc Nephrol 5 2010 275 280
32. E.J. Hoorn, F. Rivadeneira, and J.B. van Meurs Mild hyponatremia as a risk factor for fractures: the Rotterdam Study J Bone Miner Res 26 2011 1822 1828
33. J.G. Verbalis, J. Barsony, and Y. Sugimura Hyponatremia-induced osteoporosis J Bone Miner Res 25 2010 554 563
34. A. Boscoe, C. Paramore, and J.G. Verbalis Cost of illness of hyponatremia in the United States Cost Eff Resour Alloc 4 2006 10
35. S. Deitelzweig, A. Amin, R. Christian, K. Friend, J. Lin, and T.J. Lowe Health care utilization, costs, and readmission rates associated with hyponatremia Hosp Pract (1995) 41 2013 89 95
36. A. Amin, S. Deitelzweig, and R. Christian Healthcare resource burden associated with hyponatremia among patients hospitalized for heart failure in the US J Med Econ 16 2013 415 420
37. S. Deitelzweig, A. Amin, and R. Christian Hyponatremia-associated healthcare burden among US patients hospitalized for cirrhosis Adv Ther 30 2013 71 80
38. C. Williams, T.D. Simon, and J. Riva-Cambrin Hyponatremia with intracranial malignant tumor resection in children J Neurosurg Pediatr 9 2012 524 529
39. K. Turgutalp, O. Ozhan, and O.E. Gok Clinical features, outcome and cost of hyponatremia-associated admission and hospitalization in elderly and very elderly patients: a single-center experience in Turkey Int Urol Nephrol 45 2013 265 273
40. M.A. Konstam, M. Gheorghiade, and J.C. Burnett Jr. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial JAMA 297 2007 1319 1331 (Pubitemid 46513233)
41. J.F. Dasta, J.R. Chiong, R. Christian, and J. Lin Evaluation of costs associated with tolvaptan-mediated hospital length of stay reduction among US patients with the syndrome of inappropriate antidiuretic hormone secretion, based on SALT-1 and SALT-2 trials Hosp Pract (1995) 40 2012 7 14
42. J.R. Chiong, S. Kim, and J. Lin Evaluation of costs associated with tolvaptan-mediated length-of-stay reduction among heart failure patients with hyponatremia in the US, based on the EVEREST trial J Med Econ 15 2012 276 284
43. G.L. Robertson Regulation of arginine vasopressin in the syndrome of inappropriate antidiuresis Am J Med 119 2006 S36 S42
44. R.W. Schrier Water and sodium retention in edematous disorders: role of vasopressin and aldosterone Am J Med 119 2006 S47 S53
45. L.S. Weisberg Pseudohyponatremia: a reappraisal [Review] Am J Med 86 1989 315 318
46. T.A. Hillier, R.D. Abbott, and E.J. Barrett Hyponatremia: evaluating the correction factor for hyperglycemia Am J Med 106 1999 399 403 (Pubitemid 29190591)
47. A. Turchin, J.L. Seifter, and E.W. Seely Clinical problem-solving. Mind the gap N Engl J Med 349 2003 1465 1469
48. M.S. Huda, A. Boyd, and K. Skagen Investigation and management of severe hyponatraemia in a hospital setting Postgrad Med J 82 2006 216 219
49. W. Fenske, S.K. Maier, and A. Blechschmidt Utility and limitations of the traditional diagnostic approach to hyponatremia: a diagnostic study Am J Med 123 2010 652 657
50. H.M. Chung, R. Kluge, and R.W. Schrier Clinical assessment of extracellular fluid volume in hyponatremia Am J Med 83 1987 905 908 (Pubitemid 18098166)
51. R.W. Schrier Body water homeostasis: clinical disorders of urinary dilution and concentration J Am Soc Nephrol 17 2006 1820 1832 (Pubitemid 44036166)
52. W. Fenske, S. Stork, and A.C. Koschker Value of fractional uric acid excretion in differential diagnosis of hyponatremic patients on diuretics J Clin Endocrinol Metab 93 2008 2991 2997
53. T. Hato, and R. Ng Diagnostic value of urine sodium concentration in hyponatremia due to syndrome of inappropriate antidiuretic hormone secretion versus hypovolemia Hawaii Med J 69 2010 264 267
54. W.B. Schwartz, S. Bennett, and S. Curelop A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiuretic hormone Am J Med 23 1957 529 542
55. L.H. Beck Hypouricemia in the syndrome of inappropriate secretion of antidiuretic hormone N Engl J Med 301 1979 528 530 (Pubitemid 9258261)
56. C.S. Almond, A.Y. Shin, and E.B. Fortescue Hyponatremia among runners in the Boston Marathon N Engl J Med 352 2005 1550 1556
57. T. Hew-Butler, J.C. Ayus, and C. Kipps Statement of the Second International Exercise-Associated Hyponatremia Consensus Development Conference, New Zealand, 2007 Clin J Sport Med 18 2008 111 121 (Pubitemid 351365715)
58. G.H. Kim, J.W. Lee, and Y.K. Oh Antidiuretic effect of hydrochlorothiazide in lithium-induced nephrogenic diabetes insipidus is associated with upregulation of aquaporin-2, Na-Cl co-transporter, and epithelial sodium channel J Am Soc Nephrol 15 2004 2836 2843
59. M. Sonnenblick, Y. Friedlander, and A.J. Rosin Diuretic-induced severe hyponatremia. Review and analysis of 129 reported patients [Review] Chest 103 1993 601 606 (Pubitemid 23070771)
60. J.K. Hix, S. Silver, and R.H. Sterns Diuretic-associated hyponatremia Semin Nephrol 31 2011 553 566
61. K.M. Chow, B.C. Kwan, and C.C. Szeto Clinical studies of thiazide-induced hyponatremia J Natl Med Assoc 96 2004 1305 1308 (Pubitemid 39318958)
62. A.A. Leung, A. Wright, and V. Pazo Risk of thiazide-induced hyponatremia in patients with hypertension Am J Med 124 2011 1064 1072
63. Y. Sharabi, R. Illan, and Y. Kamari Diuretic induced hyponatraemia in elderly hypertensive women J Hum Hypertens 16 2002 631 635
64. K.M. Chow, C.C. Szeto, and T.Y. Wong Risk factors for thiazide-induced hyponatraemia QJM 96 2003 911 917 (Pubitemid 37540665)
65. E.M. Rodenburg, E.J. Hoorn, and R. Ruiter Thiazide-associated hyponatremia: a population-based study Am J Kidney Dis 62 1 2013 67 72
66. E. Friedman, M. Shadel, and H. Halkin Thiazide-induced hyponatremia. Reproducibility by single dose rechallenge and an analysis of pathogenesis Ann Intern Med 110 1989 24 30 (Pubitemid 19032790)
67. S. Bitew, L. Imbriano, and N. Miyawaki More on renal salt wasting without cerebral disease: response to saline infusion Clin J Am Soc Nephrol 4 2009 309 315
68. M.J. Hannon, F.M. Finucane, and M. Sherlock Clinical review: disorders of water homeostasis in neurosurgical patients J Clin Endocrinol Metab 97 2012 1423 1433
69. S. Hsieh, and P.C. White Presentation of primary adrenal insufficiency in childhood J Clin Endocrinol Metab 96 2011 E925 E928
70. F.C. Bartter, and W.B. Schwartz The syndrome of inappropriate secretion of antidiuretic hormone Am J Med 42 1967 790 806
71. M.F. Michelis, R.D. Fusco, and R.W. Bragdon Reset of osmoreceptors in association with normovolemic hyponatremia Am J Med Sci 267 1974 267 273
72. W. Fenske, S. Stork, and A. Blechschmidt Copeptin in the differential diagnosis of hyponatremia J Clin Endocrinol Metab 94 2009 123 129
73. B.J. Feldman, S.M. Rosenthal, and G.A. Vargas Nephrogenic syndrome of inappropriate antidiuresis N Engl J Med 352 2005 1884 1890 (Pubitemid 40627814)
74. G. Decaux, F. Vandergheynst, and Y. Bouko Nephrogenic syndrome of inappropriate antidiuresis in adults: high phenotypic variability in men and women from a large pedigree J Am Soc Nephrol 18 2007 606 612 (Pubitemid 46193326)
75. R. Zerbe, L. Stropes, and G. Robertson Vasopressin function in the syndrome of inappropriate antidiuresis Annu Rev Med 31 1980 315 327
76. D. Ikkos, R. Luft, and H. Olivecrona Hypophysectomy in man: effect on water excretion during the first two postoperative months J Clin Endocrinol Metab 15 1955 553 567
77. S. Diederich, N.F. Franzen, and V. Bahr Severe hyponatremia due to hypopituitarism with adrenal insufficiency: report on 28 cases Eur J Endocrinol 148 2003 609 617 (Pubitemid 36758290)
78. W. Oelkers Hyponatremia and inappropriate secretion of vasopressin (antidiuretic hormone) in patients with hypopituitarism N Engl J Med 321 1989 492 496 (Pubitemid 19203872)
79. S. Ishikawa, and R.W. Schrier Effect of arginine vasopressin antagonist on renal water excretion in glucocorticoid and mineralocorticoid deficient rats Kidney Int 22 1982 587 593 (Pubitemid 13204101)
80. F.W. Hanna, and M.F. Scanlon Hyponatraemia, hypothyroidism, and role of arginine-vasopressin Lancet 350 1997 755 756 (Pubitemid 27387200)
81. A. Chinitz, and F.L. Turner The association of primary hypothyroidism and inappropriate secretion of the antidiuretic hormone Arch Intern Med 116 1965 871 874
82. F.R. Derubertis Jr., M.F. Michelis, and M.E. Bloom Impaired water excretion in myxedema Am J Med 51 1971 41 53
83. R.A. Irving, T.D. Noakes, and R. Buck Evaluation of renal function and fluid homeostasis during recovery from exercise-induced hyponatremia J Appl Physiol 70 1991 342 348
84. D.B. Speedy, T.D. Noakes, and I.R. Rogers Hyponatremia in ultradistance triathletes Med Sci Sports Exerc 31 1999 809 815 (Pubitemid 29262672)
85. T. Noakes Fluid replacement during marathon running Clin J Sport Med 13 2003 309 318 (Pubitemid 37210527)
86. T. Hew-Butler, C. Almond, and J.C. Ayus Consensus statement of the 1st International Exercise-Associated Hyponatremia Consensus Development Conference, Cape Town, South Africa 2005 Clin J Sport Med 15 2005 208 213
87. J.C. Demanet, M. Bonnyns, and H. Bleiberg Coma due to water intoxication in beer drinkers Lancet 2 1971 1115 1117
88. S.M. Thaler, I. Teitelbaum, and T. Berl "Beer potomania" in non-beer drinkers: effect of low dietary solute intake Am J Kidney Dis 31 1998 1028 1031
89. E.D. Barlow, and H.E. DeWardner Compulsive water drinking Q J Med 28 110 1959 235 258
90. W.V. Vieweg, G.L. Robertson, and L.S. Godleski Diurnal variation in water homeostasis among schizophrenic patients subject to water intoxication Schizophrenia Res 1 1988 351 357
91. J. de Leon, C. Verghese, J.I. Tracy, R.C. Josiassen, and G.M. Simpson Polydipsia and water intoxication in psychiatric patients: a review of the epidemiological literature Bio Psychiatry 35 1994 408 419 (Pubitemid 24118470)
92. C.A. Stuart, F.A. Neelon, and H.E. Lebovitz Disordered control of thirst in hypothalamic-pituitary sarcoidosis N Engl J Med 303 1980 1078 1082 (Pubitemid 10029967)
93. R.K. Crowley, O.P. Hamnvik, and E.P. O'Sullivan Morbidity and mortality in patients with craniopharyngioma after surgery Clin Endocrinol (Oxf) 73 2010 516 521
94. T.D. Noakes, G. Wilson, and D.A. Gray Peak rates of diuresis in healthy humans during oral fluid overload S Afr Med J 91 2001 852 857 (Pubitemid 33062315)
95. J.C. Cheng, D. Zikos, and H.A. Skopicki Long-term neurologic outcome in psychogenic water drinkers with severe symptomatic hyponatremia: the effect of rapid correction Am J Med 88 1990 561 566 (Pubitemid 20192266)
96. M.B. Goldman, D.J. Luchins, and G.L. Robertson Mechanisms of altered water metabolism in psychotic patients with polydipsia and hyponatremia N Engl J Med 318 1988 397 403 (Pubitemid 18044178)
97. I.H. Zucker, L. Share, and J.P. Gilmore Renal effects of left atrial distension in dogs with chronic congestive heart failure Am J Physiol 236 1979 H554 H560
98. I.H. Zucker, A.J. Gorman, and K.G. Cornish Imparied atrial receptor modulation or renal nerve activity in dogs with chronic volume overload Cardiovasc Res 19 1985 411 418 (Pubitemid 15033669)
99. W.T. Abraham, B.D. Lowes, and D.A. Ferguson Systemic hemodynamic, neurohormonal, and renal effects of a steady-state infusion of human brain natriuretic peptide in patients with hemodynamically decompensated heart failure J Card Fail 4 1998 37 44 (Pubitemid 28252539)
100. T. Berl, P. Cadnapaphornchai, and J.A. Harbottle Mechanism of stimulation of vasopressin release during beta adrenergic stimulation with isoproterenol J Clin Invest 53 1974 857 867
101. A.H. Sklar, and R.W. Schrier Central nervous system mediators of vasopressin release Physiol Rev 63 1983 1243 1280 (Pubitemid 14213915)
102. V.L. Szatalowicz, P.E. Arnold, and C. Chaimovitz Radioimmunoassay of plasma arginine vasopressin in hyponatremic patients with congestive heart failure N Engl J Med 305 1981 263 266 (Pubitemid 11087371)
103. R.W. Schrier Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy (1) N Engl J Med 319 1988 1065 1072
104. R.W. Schrier Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy (2) N Engl J Med 319 1988 1127 1134
105. B.D. Myers, W.M. Deen, and B.M. Brenner Effects of norepinephrine and angiotensin II on the determinants of glomerular ultrafiltration and proximal tubule fluid reabsorption in the rat Circ Res 37 1975 101 110
106. P. Gines, T. Berl, and M. Bernardi Hyponatremia in cirrhosis: from pathogenesis to treatment Hepatology 28 1998 851 864 (Pubitemid 28405440)
107. R.W. Schrier, V. Arroyo, and M. Bernardi Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis Hepatology 8 1988 1151 1157
108. P.Y. Martin, P. Gines, and R.W. Schrier Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis N Engl J Med 339 1998 533 541 (Pubitemid 28384887)
109. R.W. Schrier Body fluid volume regulation in health and disease: a unifying hypothesis Ann Intern Med 113 1990 155 159 (Pubitemid 20218633)
110. D. Bichet, V. Szatalowicz, and C. Chaimovitz Role of vasopressin in abnormal water excretion in cirrhotic patients Ann Intern Med 96 1982 413 417 (Pubitemid 12139861)
111. C.P. Kovesdy, E.H. Lott, and J.L. Lu Hyponatremia, hypernatremia, and mortality in patients with chronic kidney disease with and without congestive heart failure Circulation 125 2012 677 684
112. S.S. Waikar, G.C. Curhan, and S.M. Brunelli Mortality associated with low serum sodium concentration in maintenance hemodialysis Am J Med 124 2011 77 84
113. J.J. Finley, M.A. Konstam, and J.E. Udelson Arginine vasopressin antagonists for the treatment of heart failure and hyponatremia Circulation 118 2008 410 421
114. M.L. McManus, K.B. Churchwell, and K. Strange Regulation of cell volume in health and disease N Engl J Med 333 1995 1260 1266
115. H. Pasantes-Morales, R.A. Lezama, and G. Ramos-Mandujano Mechanisms of cell volume regulation in hypo-osmolality Am J Med 119 2006 S4 S11
116. E. Sjoblom, J. Hojer, and U. Ludwigs Fatal hyponatraemic brain oedema due to common gastroenteritis with accidental water intoxication Intensive Care Med 23 1997 348 350 (Pubitemid 27130004)
117. J.G. Verbalis Brain volume regulation in response to changes in osmolality Neuroscience 168 2010 862 870
118. R.H. Sterns Severe symptomatic hyponatremia: treatment and outcome. A study of 64 cases Ann Intern Med 107 1987 656 664 (Pubitemid 18041860)
119. F.C. Helwig, C.B. Schutz, and H.P. Kuhn Water intoxication. Moribund patient cured by administration of hypertonic salt solution JAMA 110 1938 644 645
120. C. Battison, P.J. Andrews, and C. Graham Randomized, controlled trial on the effect of a 20% mannitol solution and a 7.5% saline/6% dextran solution on increased intracranial pressure after brain injury Crit Care Med 33 2005 196 202 (Pubitemid 40116557)
121. R.H. Sterns, J.E. Riggs, and S.S. Schochet Jr. Osmotic demyelination syndrome following correction of hyponatremia N Engl J Med 314 1986 1535 1542 (Pubitemid 16114683)
122. R.H. Sterns, J.D. Cappuccio, and S.M. Silver Neurologic sequelae after treatment of severe hyponatremia: a multicenter perspective J Am Soc Nephrol 4 1994 1522 1530
123. C. Odier, D.K. Nguyen, and M. Panisset Central pontine and extrapontine myelinolysis: from epileptic and other manifestations to cognitive prognosis J Neurol 257 2010 1176 1180
124. A. Soupart, R. Penninckx, and B. Namias Brain myelinolysis following hypernatremia in rats J Neuropathol Exp Neurol 55 1996 106 113 (Pubitemid 26013791)
125. J.E. Brunner, J.M. Redmond, and A.M. Haggar Central pontine myelinolysis and pontine lesions after rapid correction of hyponatremia: a prospective magnetic resonance imaging study Ann Neurol 27 1990 61 66 (Pubitemid 20031359)
126. E.A. Baker, Y. Tian, S. Adler, and J.G. Verbalis Blood-brain barrier disruption and complement activation in the brain following rapid correction of chronic hyponatremia Exp Neurol 165 2000 221 230
127. Y.H. Lien Role of organic osmolytes in myelinolysis. a topographic study in rats after rapid correction of hyponatremia J Clin Invest 95 1995 1579 1586
128. A. Soupart, S. Silver, and B. Schrooeder Rapid (24-hour) reaccumulation of brain organic osmolytes (particularly myo-inositol) in azotemic rats after correction of chronic hyponatremia J Am Soc Nephrol 13 2002 1433 1441 (Pubitemid 34579231)
129. R.H. Sterns, and S.M. Silver Brain volume regulation in response to hypo-osmolality and its correction Am J Med 119 2006 S12 S16
130. H.J. Adrogue, and N.E. Madias Hyponatremia N Engl J Med 342 2000 1581 1589 (Pubitemid 30340505)
131. R.H. Sterns, J.K. Hix, and S. Silver Treatment of hyponatremia Curr Opin Nephrol Hypertens 19 2010 493 498
132. R.H. Sterns, S.U. Nigwekar, and J.K. Hix The treatment of hyponatremia Semin Nephrol 29 2009 282 299
133. A.I. Arieff Hyponatremia, convulsions, respiratory arrest, and permanent brain damage after elective surgery in healthy women N Engl J Med 314 1986 1529 1535 (Pubitemid 16114682)
134. J.C. Ayus, J. Varon, and A.I. Arieff Hyponatremia, cerebral edema, and noncardiogenic pulmonary edema in marathon runners Ann Intern Med 132 2000 711 714 (Pubitemid 30244170)
135. J.C. Ayus, and A.I. Arieff Pulmonary complications of hyponatremic encephalopathy. noncardiogenic pulmonary edema and hypercapnic respiratory failure [see comments] Chest 107 1995 517 521
136. M.A. Koenig, M. Bryan, and J.L. Lewin III Reversal of transtentorial herniation with hypertonic saline Neurology 70 2008 1023 1029 (Pubitemid 351451321)
137. M.L. Moritz, and J.C. Ayus 100 cc 3% sodium chloride bolus: a novel treatment for hyponatremic encephalopathy Metab Brain Dis 25 2010 91 96
138. I.R. Rogers, G. Hook, and K.J. Stuempfle An intervention study of oral versus intravenous hypertonic saline administration in ultramarathon runners with exercise-associated hyponatremia: a preliminary randomized trial Clin J Sport Med 21 2011 200 203
139. S.J. Ellis Severe hyponatraemia: complications and treatment QJM 88 1995 905 909 (Pubitemid 26009659)
140. R.S. Tanneau, A. Henry, and F. Rouhart High incidence of neurologic complications following rapid correction of severe hyponatremia in polydipsic patients J Clin Psychiatry 55 1994 349 354 (Pubitemid 24286487)
141. T. Vu, R. Wong, and P.S. Hamblin Patients presenting with severe hypotonic hyponatremia: etiological factors, assessment, and outcomes Hosp Pract (1995) 37 2009 128 136
142. F.H. Cluitmans, and A.E. Meinders Management of severe hyponatremia: rapid or slow correction? [Review] Am J Med 88 1990 161 166 (Pubitemid 20051789)
143. H.J. Adrogue, and N.E. Madias The challenge of hyponatremia J Am Soc Nephrol 23 2012 1140 1148
144. M.L. Moritz, and J.C. Ayus The pathophysiology and treatment of hyponatraemic encephalopathy: an update Nephrol Dial Transplant 18 2003 2486 2491 (Pubitemid 37483780)
145. J.C. Ayus, R.K. Krothapalli, and A.I. Arieff Treatment of symptomatic hyponatremia and its relation to brain damage. A prospective study N Engl J Med 317 1987 1190 1195 (Pubitemid 17150331)
146. J.C. Ayus, R.K. Krothapalli, and A.I. Arieff Changing concepts in treatment of severe symptomatic hyponatremia. Rapid correction and possible relation to central pontine myelinolysis Am J Med 78 1985 897 902 (Pubitemid 15021251)
147. D.B. Mount The brain in hyponatremia: both culprit and victim Semin Nephrol 29 2009 196 215
148. B.I. Karp, and R. Laureno Pontine and extrapontine myelinolysis: a neurologic disorder following rapid correction of hyponatremia Medicine 72 1993 359 373 (Pubitemid 23345633)
149. C.M. Nzerue, H. Baffoe-Bonnie, and W. You Predictors of outcome in hospitalized patients with severe hyponatremia J Natl Med Assoc 95 2003 335 343 (Pubitemid 37101953)
150. J.C. Ayus, and A.I. Arieff Chronic hyponatremic encephalopathy in postmenopausal women: association of therapies with morbidity and mortality [see comments] JAMA 281 1999 2299 2304 (Pubitemid 29289822)
151. S. Arampatzis, B. Frauchiger, and G.M. Fiedler Characteristics, symptoms, and outcome of severe dysnatremias present on hospital admission Am J Med 125 2012 1125.e1 1125.e7
152. A. Perianayagam, R.H. Sterns, and S.M. Silver DDAVP is effective in preventing and reversing inadvertent overcorrection of hyponatremia Clin J Am Soc Nephrol 3 2008 331 336
153. H.K. Mohmand, D. Issa, and Z. Ahmad Hypertonic saline for hyponatremia: risk of inadvertent overcorrection Clin J Am Soc Nephrol 2 2007 1110 1117
154. R.H. Sterns, J.K. Hix, and S. Silver Treating profound hyponatremia: a strategy for controlled correction Am J Kidney Dis 56 2010 774 779
155. L. Sood, R.H. Sterns, and J.K. Hix Hypertonic saline and desmopressin: a simple strategy for safe correction of severe hyponatremia Am J Kidney Dis 61 2013 571 578
156. K.F. Gankam, A. Soupart, and R. Pochet Re-induction of hyponatremia after rapid overcorrection of hyponatremia reduces mortality in rats Kidney Int 76 2009 614 621
157. Y. Sugimura, T. Murase, and S. Takefuji Protective effect of dexamethasone on osmotic-induced demyelination in rats Exp Neurol 192 2005 178 183 (Pubitemid 40208551)
158. R.W. Schrier Treatment of hyponatremia. [Review] N Engl J Med 312 1985 1121 1123
159. M. Thibonnier, D.M. Conarty, and J.A. Preston Molecular pharmacology of human vasopressin receptors Adv Exp Med Biol 449 1998 251 276 (Pubitemid 28566397)
160. M.A. Knepper Molecular physiology of urinary concentrating mechanism: regulation of aquaporin water channels by vasopressin Am J Physiol 272 1997 F3 F12
161. A. Ohnishi, Y. Orita, and R. Okahara Potent aquaretic agent. A novel nonpeptide selective vasopressin 2 antagonist (OPC-31260) in men J Clin Invest 92 1993 2653 2659 (Pubitemid 24006529)
162. P.J. Hauptman, J.C. Burnett Jr., and M. Gheorghiade Clinical course of patients with hyponatremia and decompensated systolic heart failure and the effect of vasopressin receptor antagonism with tolvaptan J Card Fail 19 6 2013 390 397
163. Vaprisol [package insert] 2006 Astellas Pharma US, Inc. Deerfield, IL
164. D. Zeltser, S. Rosansky, and H. van Rensburg Assessment of the efficacy and safety of intravenous conivaptan in euvolemic and hypervolemic hyponatremia Am J Nephrol 27 2007 447 457 (Pubitemid 47482001)
165. Samsca [package insert] 2013 Otsuka Pharmaceutical Co Ltd Tokyo, Japan
166. V.E. Torres, A.B. Chapman, and O. Devuyst Tolvaptan in patients with autosomal dominant polycystic kidney disease N Engl J Med 367 2012 2407 2418
167. T. Berl, F. Quittnat-Pelletier, and J.G. Verbalis Oral tolvaptan is safe and effective in chronic hyponatremia J Am Soc Nephrol 21 4 2010 705 712
168. US Food and Drug Administration. Samsca (tolvaptan): drug safety communication - FDA limits duration and usage due to possible liver injury leading to organ transplant or death. Available at: http://www.fda.gov/Safety/ MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm350185.htm. Accessed June 25, 2013.
169. Direct Healthcare Professional Communication on the potential risk of liver injury with Samsca® (tolvaptan). Available at: http://www.mhra.gov.uk/ home/groups/pl-p/documents/drugsafetymessage/con282760.pdf. Accessed June 25, 2013.
170. O. Abbasoglu, R.M. Goldstein, and M.S. Vodapally Liver transplantation in hyponatremic patients with emphasis on central pontine myelinolysis Clin Transplant 12 1998 263 269 (Pubitemid 28269252)
171. M.P. Fichman, H. Vorherr, and C.R. Kleeman Diuretic-induced hyponatremia Ann Intern Med 75 1971 853 863
172. T. Berl, and A. Rastegar A patient with severe hyponatremia and hypokalemia: osmotic demyelination following potassium repletion Am J Kidney Dis 55 2010 742 748
173. S.C. Damaraju, V. Rajshekhar, and M.J. Chandy Validation study of a central venous pressure-based protocol for the management of neurosurgical patients with hyponatremia and natriuresis Neurosurgery 40 1997 312 316 discussion 316-317
174. D. Hasan, E.F. Wijdicks, and M. Vermeulen Hyponatremia is associated with cerebral ischemia in patients with aneurysmal subarachnoid hemorrhage Ann Neurol 27 1990 106 108 (Pubitemid 20031367)
175. E.F. Wijdicks, M. Vermeulen, and A. Hijdra Hyponatremia and cerebral infarction in patients with ruptured intracranial aneurysms: is fluid restriction harmful? Ann Neurol 17 1985 137 140 (Pubitemid 15170433)
176. M. Rahman, and W.A. Friedman Hyponatremia in neurosurgical patients: clinical guidelines development Neurosurgery 65 2009 925 935
177. D. Hasan, M. Vermeulen, and E.F. Wijdicks Effect of fluid intake and antihypertensive treatment on cerebral ischemia after subarachnoid hemorrhage Stroke 20 1989 1511 1515 (Pubitemid 19278138)
178. D.H. Ellison, and T. Berl Clinical practice. The syndrome of inappropriate antidiuresis N Engl J Med 356 2007 2064 2072 (Pubitemid 46789896)
179. G.L. Robertson Posterior pituitary P. Felig, J. Baxter, A. Broadus, L. Frohman, Endocrinology and Metabolism 1986 McGraw-Hill Inc. Medical Publishing Division New York 338 385
180. A.F. List, J.D. Hainsworth, and B.W. Davis The syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in small-cell lung cancer J Clin Oncol 4 1986 1191 1198 (Pubitemid 16043869)
181. D.A. Cherrill, R.M. Stote, and J.R. Birge Demeclocycline treatment in the syndrome of inappropriate antidiuretic hormone secretion Ann Intern Med 83 1975 654 656
182. T.P. Dousa, and D.M. Wilson Effect of demethylchlorotetracycline on cellular action of antidiuretic hormone in vitro Kidney Int 5 1974 279 284
183. P.D. Miller, S.L. Linas, and R.W. Schrier Plasma demeclocycline levels and nephrotoxicity. Correlation in hyponatremic cirrhotic patients JAMA 243 1980 2513 2515 (Pubitemid 10039244)
184. J.G. Verbalis, E.F. Baldwin, P.N. Neish, and A.G. Robinson Effect of protein intake and urea on sodium excretion during inappropriate antidiuresis in rats Metabolism 37 1988 46 54 (Pubitemid 18057195)
185. J. Coussement, C. Danguy, and K. Zouaoui-Boudjeltia Treatment of the syndrome of inappropriate secretion of antidiuretic hormone with urea in critically ill patients Am J Nephrol 35 2012 265 270
186. G. Decaux, C. Andres, K.F. Gankam, F. Kengne, and A. Soupart Treatment of euvolemic hyponatremia in the intensive care unit by urea Crit Care 14 2010 R184
187. H. Chehade, L. Rosato, and E. Girardin Inappropriate antidiuretic hormone secretion: long-term successful urea treatment Acta Paediatr 101 2012 e39 e42
188. E.N. Levtchenko, and L.A. Monnens Nephrogenic syndrome of inappropriate antidiuresis Nephrol Dial Transplant 25 2010 2839 2843
189. A. Soupart, M. Coffernils, and B. Couturier Efficacy and tolerance of urea compared with vaptans for long-term treatment of patients with SIADH Clin J Am Soc Nephrol 7 2012 742 747
190. G.L. Robertson, P. Aycinena, and R.L. Zerbe Neurogenic disorders of osmoregulation Am J Med 72 1982 339 353 (Pubitemid 12191851)
191. J.G. Verbalis, D. Zeltser, and N. Smith Assessment of the efficacy and safety of intravenous conivaptan in patients with euvolaemic hyponatraemia: subgroup analysis of a randomized, controlled study Clin Endocrinol (Oxf) 69 2008 159 168 (Pubitemid 351847263)
192. D. Annane, G. Decaux, and N. Smith Efficacy and safety of oral conivaptan, a vasopressin-receptor antagonist, evaluated in a randomized, controlled trial in patients with euvolemic or hypervolemic hyponatremia Am J Med Sci 337 2009 28 36
193. A.M. Naidech, J. Paparello, and S.M. Liebling Use of Conivaptan (Vaprisol) for hyponatremic neuro-ICU patients Neurocrit Care 13 2010 57 61
194. J.G. Verbalis, S. Adler, and R.W. Schrier Efficacy and safety of oral tolvaptan therapy in patients with the syndrome of inappropriate antidiuretic hormone secretion Eur J Endocrinol 164 5 2011 725 732
195. C.J. Thompson, S.N. Davis, and P.H. Baylis Effect of blood glucose concentration on osmoregulation in diabetes mellitus Am J Physiol 256 1989 R597 R604
196. th ed M.W. Taal, G.M. Chertow, P.A. Marsden, K. Skorecki, A.S.L. Yu, B.M. Brenner, Brenner and Rector's The Kidney Vol 1 2012 Saunders/Elsevier Philadelphia 540 594
197. E.A. Huang, B.J. Feldman, and I.D. Schwartz Oral urea for the treatment of chronic syndrome of inappropriate antidiuresis in children J Pediatr 148 2006 128 131 (Pubitemid 43098970)
198. G.L. Robertson Abnormalities of thirst regulation Kidney Int 25 1984 460 469 (Pubitemid 14142836)
199. C.M. Canuso, and M.B. Goldman Clozapine restores water balance in schizophrenic patients with polydipsia-hyponatremia syndrome J Neuropsychiatry Clin Neurosci 11 1999 86 90 (Pubitemid 29070669)
200. N. Kawai, A. Baba, and T. Suzuki Risperidone failed to improve polydipsia-hyponatremia of the schizophrenic patients Psychiatry Clin Neurosci 56 2002 107 110 (Pubitemid 34130628)
201. G.S. Francis, R.M. Siegel, and S.R. Goldsmith Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis Ann Intern Med 103 1985 1 6 (Pubitemid 15068490)
202. G. Decaux Is asymptomatic hyponatremia really asymptomatic? Am J Med 119 2006 S79 S82
203. G. Licata, P. Di Pasquale, and G. Parrinello Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects Am Heart J 145 2003 459 466 (Pubitemid 36390492)
204. S.R. Goldsmith Vasopressin receptor antagonists: mechanisms of action and potential effects in heart failure Cleve Clin J Med 73 Suppl 2 2006 S20 S23
205. J.K. Ghali, C. Orlandi, and W.T. Abraham The efficacy and safety of lixivaptan in outpatients with heart failure and volume overload: results of a multicentre, randomized, double-blind, placebo-controlled, parallel-group study Eur J Heart Fail 14 2012 642 651
206. S.R. Goldsmith, F. Brandimarte, and M. Gheorghiade Congestion as a therapeutic target in acute heart failure syndromes Prog Cardiovasc Dis 52 2010 383 392
207. J.M. Testani, J. Chen, and B.D. McCauley Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival Circulation 122 2010 265 272
208. J. Rossi, M. Bayram, and J.E. Udelson Improvement in hyponatremia during hospitalization for worsening heart failure is associated with improved outcomes: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) trial Acute Card Care 9 2007 82 86 (Pubitemid 46955230)
209. J. Tamargo, and J. Lopez-Sendon Novel therapeutic targets for the treatment of heart failure Nat Rev Drug Discov 10 2011 536 555
210. A. Ambrosy, S.R. Goldsmith, and M. Gheorghiade Tolvaptan for the treatment of heart failure: a review of the literature Expert Opin Pharmacother 12 2011 961 976
211. M. Gheorghiade, W.A. Gattis, and C.M. O'Connor Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial JAMA 291 2004 1963 1971 (Pubitemid 38544277)
212. S.R. Goldsmith, and M. Gheorghiade Vasopressin antagonism in heart failure J Am Coll Cardiol 46 2005 1785 1791 (Pubitemid 41579797)
213. A. Singh, J. Blackwell, and J. Neher Clinical inquiries. Does furosemide decrease morbidity or mortality for patients with diastolic or systolic dysfunction? J Fam Pract 54 2005 370 372 (Pubitemid 40489437)
214. S.R. Goldsmith, D.T. Gilbertson, and S.A. Mackedanz Renal effects of conivaptan, furosemide, and the combination in patients with chronic heart failure J Card Fail 17 2011 982 989
215. J.E. Udelson, M. Bilsker, and P.J. Hauptman A multicenter, randomized, double-blind, placebo-controlled study of tolvaptan monotherapy compared to furosemide and the combination of tolvaptan and furosemide in patients with heart failure and systolic dysfunction J Card Fail 17 2011 973 981
216. M. Guevara, M.E. Baccaro, and A. Torre Hyponatremia is a risk factor of hepatic encephalopathy in patients with cirrhosis: a prospective study with time-dependent analysis Am J Gastroenterol 104 2009 1382 1389
217. J. Cordoba, R. Garcia-Martinez, and M. Simon-Talero Hyponatremic and hepatic encephalopathies: similarities, differences and coexistence Metab Brain Dis 25 2010 73 80